GILLIS EDWARD M 4
4 · BioCardia, Inc. · Filed May 22, 2023
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
GILLIS EDWARD M
Senior Vice President, Devices
Transactions
- Award
Common Stock
2023-05-18$1.70/sh+40,490$68,833→ 40,490 total - Award
Stock Option (right to buy)
2023-05-18+43,803→ 43,803 totalExercise: $1.70Exp: 2033-05-18→ Common Stock (43,803 underlying)
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023.
- [F2]The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.